29 related articles for article (PubMed ID: 18374895)
1. Engaging stimulatory immune checkpoint interactions in the tumour immune microenvironment of primary liver cancers - how to push the gas after having released the brake.
Rakké YS; Buschow SI; IJzermans JNM; Sprengers D
Front Immunol; 2024; 15():1357333. PubMed ID: 38440738
[TBL] [Abstract][Full Text] [Related]
2. Identification of microenvironment related potential biomarkers of biochemical recurrence at 3 years after prostatectomy in prostate adenocarcinoma.
Sun X; Wang L; Li H; Jin C; Yu Y; Hou L; Liu X; Yu Y; Yan R; Xue F
Aging (Albany NY); 2021 Jun; 13(12):16024-16042. PubMed ID: 34133324
[TBL] [Abstract][Full Text] [Related]
3. FcγRIIB engagement drives agonistic activity of Fc-engineered αOX40 antibody to stimulate human tumor-infiltrating T cells.
Campos Carrascosa L; van Beek AA; de Ruiter V; Doukas M; Wei J; Fisher TS; Ching K; Yang W; van Loon K; Boor PPC; Rakké YS; Noordam L; Doornebosch P; Grünhagen D; Verhoef K; Polak WG; IJzermans JNM; Ni I; Yeung YA; Salek-Ardakani S; Sprengers D; Kwekkeboom J
J Immunother Cancer; 2020 Sep; 8(2):. PubMed ID: 32900860
[TBL] [Abstract][Full Text] [Related]
4. New pathways in immune stimulation: targeting OX40.
Alves Costa Silva C; Facchinetti F; Routy B; Derosa L
ESMO Open; 2020 Feb; 5(1):. PubMed ID: 32392177
[TBL] [Abstract][Full Text] [Related]
5. Inflammation markers in cutaneous melanoma - edgy biomarkers for prognosis.
Neagu M; Constantin C; Dumitrascu GR; Lupu AR; Caruntu C; Boda D; Zurac S
Discoveries (Craiova); 2015 Mar; 3(1):e38. PubMed ID: 32309563
[TBL] [Abstract][Full Text] [Related]
6. Inflammation: A key process in skin tumorigenesis.
Neagu M; Constantin C; Caruntu C; Dumitru C; Surcel M; Zurac S
Oncol Lett; 2019 May; 17(5):4068-4084. PubMed ID: 30944600
[TBL] [Abstract][Full Text] [Related]
7. Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.
Turaj AH; Cox KL; Penfold CA; French RR; Mockridge CI; Willoughby JE; Tutt AL; Griffiths J; Johnson PWM; Glennie MJ; Levy R; Cragg MS; Lim SH
Sci Rep; 2018 Feb; 8(1):2278. PubMed ID: 29396470
[TBL] [Abstract][Full Text] [Related]
8. OX40+ Regulatory T Cells in Cutaneous Squamous Cell Carcinoma Suppress Effector T-Cell Responses and Associate with Metastatic Potential.
Lai C; August S; Albibas A; Behar R; Cho SY; Polak ME; Theaker J; MacLeod AS; French RR; Glennie MJ; Al-Shamkhani A; Healy E
Clin Cancer Res; 2016 Aug; 22(16):4236-48. PubMed ID: 27034329
[TBL] [Abstract][Full Text] [Related]
9. Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.
Kaufman KL; Mactier S; Armstrong NJ; Mallawaaratchy D; Byrne SN; Haydu LE; Jakrot V; Thompson JF; Mann GJ; Scolyer RA; Christopherson RI
Clin Exp Metastasis; 2014 Apr; 31(4):407-21. PubMed ID: 24435119
[TBL] [Abstract][Full Text] [Related]
10. Clinical targeting of the TNF and TNFR superfamilies.
Croft M; Benedict CA; Ware CF
Nat Rev Drug Discov; 2013 Feb; 12(2):147-68. PubMed ID: 23334208
[TBL] [Abstract][Full Text] [Related]
11. Current concepts of metastasis in melanoma.
Zbytek B; Carlson JA; Granese J; Ross J; Mihm MC; Slominski A
Expert Rev Dermatol; 2008 Oct; 3(5):569-585. PubMed ID: 19649148
[TBL] [Abstract][Full Text] [Related]
12. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
[TBL] [Abstract][Full Text] [Related]
13. Optimal detection of sentinel lymph node metastases by intraoperative radioactive threshold and molecular analysis in patients with melanoma.
Manca G; Romanini A; Pellegrino D; Borsò E; Rondini M; Orlandini C; Zucchi V; Pasqualetti F; Mariani G
J Nucl Med; 2008 Nov; 49(11):1769-75. PubMed ID: 18927334
[TBL] [Abstract][Full Text] [Related]
14. Experimental frontiers for clinical applications: novel approaches to understanding mechanisms of lymph node metastases in melanoma.
Essner R
Cancer Metastasis Rev; 2006 Jun; 25(2):257-67. PubMed ID: 16770538
[TBL] [Abstract][Full Text] [Related]
15. Sentinel lymph node sampling in gynaecological cancers: techniques and clinical applications.
El-Ghobashy AE; Saidi SA
Eur J Surg Oncol; 2009 Jul; 35(7):675-85. PubMed ID: 18980825
[TBL] [Abstract][Full Text] [Related]
16. OX40 (CD134) expression in sentinel lymph nodes correlates with prognostic features of primary melanomas.
Sarff M; Edwards D; Dhungel B; Wegmann KW; Corless C; Weinberg AD; Vetto JT
Am J Surg; 2008 May; 195(5):621-5; discussion 625. PubMed ID: 18374895
[TBL] [Abstract][Full Text] [Related]
17. An increased number of sentinel lymph nodes is associated with advanced Breslow depth and lymphovascular invasion in patients with primary melanoma.
Schmidt CR; Panageas KS; Coit DG; Patel A; Brady MS
Ann Surg Oncol; 2009 Apr; 16(4):948-52. PubMed ID: 19194758
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
